Semax is part of the Novusyn Research editorial desk. Independent compound file on Semax (MEHFPGP) — ACTH(4-10) analogue, BDNF/TrkB neuroprotective mechanism, Russian clinical evidence in stroke and TBI, and global regulatory status. This prerendered HTML exists so crawlers see route-specific content before the client app hydrates.
For adjacent coverage, see the news desk, clinical trials tracker, regulation tracker, guides library, and the compound directory. Novusyn Research publishes neutral, research-only reference material and does not sell compounds or provide medical advice.